Skip to main content

Table 2 Clinico-pathological and KIT-IHC details of the immunopositive meningioma cases

From: Expression of proto-oncogene KIT is up-regulated in subset of human meningiomas

 

Details

Meningioma Cases

M10

M14

M15

M16

M21

M29

M37

Clinico-pathological details

Age

79

48

59

32

51

44

49

Gender

Ml

Fl

Fl

Fl

Fl

Fl

Fl

Grade

I

I

I

I

I

II

I

Variant/sub-type

Mg

T

Mg

T

Fb

At

T

Tumor location

RSW

LPP

PS

FM

LP

RF

LO

Recurrent case

–

–

–

–

–

–

–

Details of KIT-IHC analyses

% positivity a

4

2

2-4

1

4

3

1

Staining intensity b

W

Md

W-Md

W

S

S

W

Stain localization c

C

C

C

C

C

C

C

Staining pattern c

D,G

F,G

H,G

H,G

D

D

F,G

  1. (Clinical data: Ml, Male; Fl, Female. Ag, Angiomatous; At, Atypical; Ap, Anaplastic; Fb, Fibroblastic; Mg, Meningothelial; T, Transitional; FM, Foramen magnum; LO, Left occipital; LP, Left Parietal; LPP, Left parietal parasaggital; PS, Planum sphenoidale; RF, Right frontal; RSW, Right sphenoid wing.
  2. Experimental data: a 0 = 0%, 1 + = 1–10%, 2 + = 11–50%, 3 + = 51–75%, 4 + = ≥ 75.
  3. b W, Weak (+); Md, Moderate (++); S, Strong (+++).
  4. c C, Cytoplasmic; D, Diffuse; F, Focal; G, Granular; H, Homogeneous.